Last reviewed · How we verify
NCT05270941
Platelet-Rich Fibrin Prepared With Titanium in the Treatment of Multiple Gingival Recessions
NA trial testing COMPARISON OF PLATELET-RICH FIBRIN PREPARED WITH TITANIUM AND SUBEPITHELIAL CONNECTIVE TISSUE GRAFT in Gingival Recession in 20 participants. Completed in 30 November 2020.
29 November 2020
Quick facts
| Lead sponsor | Necmettin Erbakan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 20 |
| Start date | 12 January 2019 |
| Primary completion | 29 November 2020 |
| Estimated completion | 30 November 2020 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- COMPARISON OF PLATELET-RICH FIBRIN PREPARED WITH TITANIUM AND SUBEPITHELIAL CONNECTIVE TISSUE GRAFT
Conditions studied
- Gingival Recession — all drugs for Gingival Recession →
Sponsor
Necmettin Erbakan University
Who can join
Adults 18 to 65, any sex, with Gingival Recession. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to treat the areas with Miller Class I bilateral multiple gingival recession in the maxillary teeth using the Titanium Platelet-Rich Fibrin (T-PRF), an autogenous biomaterial applied in combination with a Modified Coronally Positioned Flap (MCPF) prepared using microsurgical techniques, and the gold standard Subepithelial Connective Tissue Graft (SCTG), to evaluate the efficacy of the treatments and to compare the clinical results 6 months after the treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05270941
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gingival Recession
Currently open trials in the same condition.
- NCT07513792 — The Impact of a 3D Imaging Tool on Reducing Gum Recession During Orthodontic Treatment With Aligners · NA · recruiting
- NCT07437417 — A Novel Volume Stable Matrix for Gingival Recession Coverage at Teeth · NA · recruiting
- NCT07158541 — Comparing TCAF and MTUN With Soft Tissue Grafting for Treating Single Recessions in the Premandible · NA · recruiting
- NCT07104019 — Biofiller and Gingival Phenotype Thickening · NA · recruiting
- NCT07291583 — Hyaluronic Acid With Connective Tissue Grafting for Gingival Recession · NA · active not recruiting
Other Necmettin Erbakan University trials
Trials by the same sponsor.
- NCT07128407 — PMT-Based Radiation Safety Training for Nurses: Randomized Controlled Trial. · NA · active not recruiting
- NCT07504770 — Surgical Glove Compression to Prevent Paclitaxel Neuropathy · NA · not yet recruiting
- NCT07242807 — Minimally Invasive Prostate Interventions Registry (MIST Study) · not yet recruiting
- NCT07442331 — The Effect of Game-Based Learning on Identifying Cognitive Distortions and Interpersonal Communication Competence in Nur · NA · completed
- NCT07396038 — INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05270941 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Necmettin Erbakan University
- Last refreshed: 8 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05270941.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing